Origins of cancer therapy.

This is a brief overview of the development of cancer therapy with a focus on systemic therapy. The modern era of chemotherapy developed at Yale University Medical School during World War II, a fact that has been generally unrecognized until recently. The observations preceding and involved in the discovery of effective drugs for cancer seem particularly pertinent for this anniversary year.

• Publication year

  2001

• Venue

  The Yale Journal of Biology and Medicine

• Publication date

  2001-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 11922186PMCID 2588755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

  2001cited by this paper
• Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide

  2001cited by this paper
• Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy.

  1999cited by this paper
• Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients.

  1997cited by this paper
• Cancer: Principles and Practice of Oncology

  1983cited by this paper
• [The contraceptive pill and vascular accidents].

  1983cited by this paper
• Historic milestones in radiobiology and radiation therapy.

  1979cited by this paper
• The historical development of cancer chemotherapy.

  1977cited by this paper
• [Glucagon therapy in acute pancreatitis].

  1974cited by this paper
• History of the Cancer Chemotherapy Program.

  1966cited by this paper
• Bleeding Disorders

  1966cited by this paper
• The initial clinical trial of nitrogen mustard.

  1963cited by this paper
• [Treatment of leukemia].

  1955cited by this paper
• The cancer problem.

  1950cited by this paper
• Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid.

  1948cited by this paper
• EFFECT OF β-CHLORETHYLAMINE HYDROCHLORIDES IN LEUKÆMIA, HODGKIN'S DISEASE, AND POLYCYTHÆMIA VERA: REPORT ON EIGHTEEN CASES

  1947cited by this paper
• The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides.

  1946cited by this paper
• The biological actions and therapeutic applications of the B-chloroethyl amines and sulfides.

  1946cited by this paper
• Nitrogen mustards in the treatment of neoplastic disease; official statement.

  1946cited by this paper
• Nitrogen mustard therapy; studies on the effect of methyl-bis (beta-chloroethyl) amine hydrochloride on neoplastic diseases and allied disorders of the hemopoietic system.

  1946cited by this paper
• STUDIES ON PROSTATIC CANCER: II. THE EFFECTS OF CASTRATION ON ADVANCED CARCINOMA OF THE PROSTATE GLAND

  1941cited by this paper
• The Papyrus Ebers; The Greatest Egyptian Medical Document

  1938cited by this paper
• The establishment of the C3H inbred strain of mice for the study of spontaneous carcinoma of the mammary gland

  1935cited by this paper
• Experimental inhibition of tumour induction by mustard gas and other compounds

  1935cited by this paper
• An Exhibit of Important Books, Papers, and Memorabilia Illustrating the Evolution of the Knowledge of Cancer: For the Graduate Fortnight on Tumors at the New York Academy of Medicine, October 17 to 28, 1932

  1933cited by this paper
• EXPERIMENTAL AND CLINICAL STUDIES ON THE TREATMENT OF CANCER BY DICHLORETHYLSULPHIDE (MUSTARD GAS)

  1931cited by this paper
• The modifying influence of dichloro‐ethyl sulphide on the induction of tumours in mice by tar

  1929cited by this paper
• The Treatment of Flexner-Jobling Rat Carcinomas with Bacterial Proteolytic Ferments

  1927cited by this paper
• The Blood and Bone Marrow in Yelloe Cross Gas (Mustard Gas) Poisoning: Changes produced in the Bone Marrow of Fatal Cases.

  1919cited by this paper
• RÔLE OF THE BLOOD AND THE BONE MARROW IN CERTAIN FORMS OF GAS POISONING: I. PERIPHERAL BLOOD CHANGES AND THEIR SIGNIFICANCE

  1919cited by this paper
• REPORT OF CASES TREATED WITH ROENTGEN RAYS.

  1902cited by this paper
• On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases

  1896cited by this paper
• TREATMENT OF INOPERABLE MALIGNANT TUMORS WITH THE TOXINES OF ERYSIPELAS AND THE BACILLUS PRODIGIOSUS

  1894cited by this paper
• Action of Iron, Cod-liver Oil, and Arsenic on the Globular Richness of the Blood

  year unknowncited by this paper

• Natural bioactive molecules and chemotherapeutics synergism for enhanced cancer therapy.

  2026cites this paper
• The Persistent Power of the Taxane/Platin Chemotherapy

  2025cites this paper
• Isotretinoin as a Multifunctional Anticancer Agent: Molecular Mechanisms, Pharmacological Insights and Therapeutic Potential

  2025cites this paper
• History of Leukemia, Revisited

  2025influential citation
• Advancements and challenges in brain cancer therapeutics

  2024cites this paper
• Precision Meets Repurposing: Innovative Approaches in Human Papillomavirus and Epstein-Barr Virus-Driven Cancer Therapy.

  2024cites this paper
• Aptamers in cancer therapy: problems and new breakthroughs.

  2023cites this paper
• Undefeated Cancer

  2023cites this paper
• A Comprehensive Review on Targeted Cancer Therapy: New Face of Treatment Approach.

  2023cites this paper
• A Dual Cox Model Theory And Its Applications In Oncology

  2023cites this paper
• Development of "smart" drug delivery systems for chemo/PDT synergistic treatment.

  2023cites this paper
• Mechano-modulation of T cells for cancer immunotherapy.

  2023cites this paper
• A study on the Side Effects of Chemotherapy and Adjuvant Treatment

  2023cites this paper
• Interactions of Mn complexes with DNA: the relevance of therapeutic applications towards cancer treatment.

  2023cites this paper
• State-of-the-art of ultrasound-triggered drug delivery from ultrasound-responsive drug carriers

  2022cites this paper
• Ultrasound-activated nanomaterials for sonodynamic cancer theranostics.

  2022cites this paper
• Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics

  2022cites this paper
• The past, present, and future of chemotherapy with a focus on individualization of drug dosing.

  2022cites this paper
• Tailoring carrier-free nanocombo of small-molecule prodrug for combinational cancer therapy.

  2022cites this paper
• A technical note on emerging combination approach involved in the onconanotherapeutics

  2022cites this paper
• Design, synthesis and computational study of new benzofuran hybrids as dual PI3K/VEGFR2 inhibitors targeting cancer

  2022cites this paper
• Recombinant protein polymers as carriers of chemotherapeutic agents.

  2022cites this paper
• Improved Delivery Performance of n-Butylidenephthalide-Polyethylene Glycol-Gold Nanoparticles Efficient for Enhanced Anti-Cancer Activity in Brain Tumor

  2022cites this paper
• Role of Natural Products in Developing Novel Anticancer Agents: A Perspective

  2022cites this paper
• Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy

  2022cites this paper
• Evolution of Medical Approaches and Prominent Therapies in Breast Cancer

  2022cites this paper
• Molecular tests for prediction of tumor sensitivity to cytotoxic drugs.

  2021cites this paper
• PHYTOCHEMICAL SCREENING, TOXICITY EVALUATION OF POLYCARPAEA CORYMBOSA LAMK AND ITS EFFECT ON CANCER BIOMARKERS OF EHRLICH ASCITES CARCINOMA-INDUCED MICE COMPARED WITH THE REFERENCE STANDARD DRUG 5- FLUOROURACIL

  2021cites this paper
• Individualized targeted therapy in oncology is highly needed in modern era of Radiation oncology practices!

  2021cites this paper
• Brain tumour: causes, symptoms, diagnosis and radiotherapy treatment.

  2021cites this paper
• Drug Combination in Cancer Treatment—From Cocktails to Conjugated Combinations

  2021influential citation
• Antibody-drug combination therapy in cancer treatment

  2021cites this paper
• Melflufen: A Journey from Discovery to Multi-Kilogram Production

  2020cites this paper
• Angelica sinensis polysaccharides ameliorate 5-flourouracil-induced bone marrow stromal cell proliferation inhibition via regulating Wnt/β-catenin signaling

  2020cites this paper
• Testung potenzieller Therapeutika zur Behandlung nach S-Lost-Exposition in Hautmodellen

  2020cites this paper
• Principles of Chemotherapy in Hodgkin Lymphoma

  2020cites this paper
• Tumor Therapeutic Modes

  2020cites this paper
• New Nanomaterials and Techniques for Tumor-targeted Systems

  2020cites this paper
• Metal complexes in medicine and pharmacy - the past and the present II.

  2020cites this paper
• The importance of protein corona for cancer therapy: interactions between albumin and carbon nanotubes

  2019cites this paper
• Avicenna’s Concepts on Cancer Metastasis from the 11th Century

  2019cites this paper
• A CONCISE HISTORY ON CHEMOTHERAPY

  2019cites this paper
• Natural Products and Synthetic Analogs as a Source of Antitumor Drugs

  2019cites this paper
• Combinational delivery therapies of nucleic acids for cancer treatment

  2019cites this paper
• Effects of Creatine Monohydrate Supplementation on Cytochrome C and Caspase-9 Expression in Skeletal Muscles from Doxorubicin Treated Rats

  2019cites this paper
• Modulation of the reactivity of nitrogen mustards by metal complexation: approaches to modify their therapeutic properties.

  2019cites this paper
• Synthesis, characterization, and biological evaluation of new spebrutinib analogues: potential candidates with enhanced activity and reduced toxicity profiles

  2019cites this paper
• Factors associated with breast MRI use among women with a family history of breast cancer

  2018cites this paper
• Enhanced anticancer potency by thermo/pH-responsive PCL-based magnetic nanoparticles

  2018cites this paper
• Use of Plant Secondary Metabolites as Nutraceuticals for Treatment and Management of Cancer: Approaches and Challenges

  2018cites this paper
• La atención del cáncer en el Ecuador: pasado, presente y futuro

  2018cites this paper
• Mitochondria in cancer metabolism, an organelle whose time has come?

  2018cites this paper
• MicroRNAs in cancer drug resistance: Basic evidence and clinical applications

  2018cites this paper
• Tuberculosis: mother of thoracic surgery then and now, past and prospectives: a review.

  2018cites this paper
• Ultrasound Triggered Release of Estrone- Targeted Liposomes

  2017cites this paper
• Synthèse et évaluation pharmacologique d’analogues préactivés de l’ifosfamide : prodrogues et nanoparticules à visée antitumorale

  2017cites this paper
• Chapter 8 – Nanoparticle System for Anticancer Drug Delivery: Targeting to Overcome Multidrug Resistance

  2017cites this paper
• Surgical Oncology Overview

  2017cites this paper
• Biological interactions between cell populations in heterogeneous tumour spheroids

  2017cites this paper
• Progress in the Discovery of BCR-ABL Kinase Inhibitors for the Treatment of Leukemia

  2017cites this paper
• Biomaterial-based regional chemotherapy: Local anticancer drug delivery to enhance chemotherapy and minimize its side-effects.

  2016cites this paper
• GROWTH OF MALIGNANT CELLS AND THERMODYNAMICS

  2016cites this paper
• Taimsete produktide roll keemiaravi arengus

  2016influential citation
• Recent advances of cocktail chemotherapy by combination drug delivery systems.

  2016cites this paper
• Antibody Therapeutics in Oncology

  2016cites this paper
• Anti-cancer Drug Delivery Using Metal Organic Frameworks (MOFs).

  2016cites this paper
• ANTIPROLIFERATIVE, ADME AND POTENTIAL IN SILICO G6PDH INHIBITORY ACTIVITY OF NOVEL 2-(1-BENZOFURAN-2-YL)-4-(5-PHENYL-4H-1, 2, 4-TRIAZOL-3-YL) QUINOLINE DERIVATIVES

  2016cites this paper
• Improving Techniques for Cell Implantation and their Impact on Managing Diseases of the Pancreas

  2016cites this paper
• Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.

  2015cites this paper
• Erratum to: Can the chemotherapeutic agents perform anticancer activity through miRNA expression regulation? Proposing a new hypothesis

  2015cites this paper
• Can the chemotherapeutic agents perform anticancer activity though miRNA expression regulation? Proposing a new hypothesis

  2015cites this paper
• Cancer: A Molecular Curse?

  2015cites this paper
• Development of novel anti-cancer prodrug strategies

  2015cites this paper
• CANCER: A MOLECULAR CURSE? Review Article

  2015cites this paper
• Targeted Cancer Therapy: History and Development of Immunotoxins

  2015cites this paper
• Pemetrexed, A Modulator of AMP-activated Kinase Signaling and an Inhibitor of Wild type and Mutant p53

  2015cites this paper
• Carcinogénesis y complejidad

  2015cites this paper
• Effect of Size and Functionalization of Pharmaceutical Nanoparticles and Their Interaction with Biological Systems

  2015cites this paper
• Synthesis and biological effects of new hybrid compounds composed of benzylguanidines and the alkylating group of busulfan on neuroblastoma cells.

  2014cites this paper
• Timing of initial antibiotic treatment for febrile neutropenia in the emergency department: the need for evidence-based guidelines.

  2014cites this paper
• Molecular Biology of Cancer

  2014cites this paper
• Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

  2014cites this paper
• An analysis of FDA-approved drugs for oncology.

  2014cites this paper
• Long Term Effects of Chemotherapy on Cognition, Preventative Potential of Antidepressants

  2014influential citation
• Rationale for the design of an oncology trial using a generic targeted therapy multi-drug regimen for NSCLC patients without treatment options (Review)

  2013cites this paper
• UNIVERSIDADE FEDERAL DO CEARÁ FACULDADE DE MEDICINA DEPARTAMENTO DE FISIOLOGIA E FARMACOLOGIA PROGRAMA DE PÓS-GRADUAÇÃO EM FARMACOLOGIA (MESTRADO PROFISSIONAL)

  2013cites this paper
• Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy

  2013cites this paper
• Monoclonal Antibodies in Cancer

  2013cites this paper
• Thin-Layer Chromatography of Anticancer Drugs

  2013cites this paper
• ChemoImmunoModulation: Focus on Myeloid Regulatory Cells

  2013influential citation
• Synthese eines zytostatisch wirksamen isomeren Calothrixin B-Derivats

  2012cites this paper
• Studies on cytotoxic activity of organometallic complexes of Mo(II) with α-diimines

  2012cites this paper
• Identification of novel compounds in Undaria pinnatifida with anti-cancer potential

  2012cites this paper
• Ashorthistoryofanti-rheumatictherapy VIII.Theimmunosuppressants

  2012cites this paper
• Targeted cancer therapies: an overview

  2012cites this paper
• Childhood Leukemias: History of leukemia: historical perspectives

  2012cites this paper
• Mucositis Prevention for Patients Receiving High Dose Chemotherapy and Stem Cell Transplantation : Preventive Strategies - There is Always More to do

  2012cites this paper
• A short history of anti-rheumatic therapy VIII . The immunosuppressants

  2012cites this paper
• Clinical trials of small molecule inhibitors in high-grade glioma.

  2012cites this paper
• Observations of unprecedented remissions following novel treatment for acute leukemia in children in 1948

  2012cites this paper